Driving the expansion of mRNA into the therapeutic sphere

Cell & Gene Therapy Insights 2023; 9(6), 783


Published: 12 July
Alejandro Becerra, Andreas Kuhn, Metin Kurtoglu

The advanced therapies industry is heavily engaged in capitalizing upon the success of mRNA-based COVID-19 vaccines. Novel therapeutic applications in major disease areas, including oncology, continue to show promise in preclinical and early clinical studies, yet challenges remain. Cell & Gene Therapy Insights brought together a panel of industry experts to discuss the expanding reach of mRNA technology, exploring how and where it will impact the advanced therapies space moving forward.